Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins

Karakaya A., Ibis S., Kural T., Kose S. K., Karakaya A.

CHEMICO-BIOLOGICAL INTERACTIONS, sa.3, ss.193-200, 1999 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 1999
  • Doi Numarası: 10.1016/s0009-2797(99)00085-x
  • Dergi Adı: CHEMICO-BIOLOGICAL INTERACTIONS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.193-200
  • Anahtar Kelimeler: paraoxonase, high-density lipoprotein, coronary heart disease, DEPENDENT DIABETES-MELLITUS, LOW-DENSITY-LIPOPROTEIN, MYOCARDIAL-INFARCTION, ARTERY DISEASE, GLN-ARG192 POLYMORPHISM, GENE POLYMORPHISM, MOLECULAR-BASIS, INCREASED RISK, HUMPONA GENE, ARYLESTERASE
  • Ankara Üniversitesi Adresli: Evet

Özet

Recently, biochemical studies of paraoxonase in the serum of humans have shown that much of this enzymes' activity is associated with high-density lipoprotein (HDL) and paraoxonase may play a role in lipid metabolism preventing the accumulation of the lipoperoxides. In this study, a possible relationship between coronary heart disease (CHD) and paraoxonase activity were investigated. Serum triglycerides, total cholesterol, HDL-cholesterol and paraoxonase activity were measured in unrelated healthy donors and CHD patients. It was found that paraoxonase activity was trimodally distributed in both groups but no statistically significant difference was found between phenotype distributions of controls and CHD patients (gene frequencies; 0.632 and 0.382 of controls, 0.702 and 0.298 of patients for the A and B alleles, respectively). However, in CHD group, a high possibility was found to be phenotype A compared with the control group. A relative risk of 1.48 (95% confidence intervals (CI)? 0.986-2.227) was found for the relation between CHD and the paraoxonase activity. Patients' HDL-cholesterol values were lower and triglycerides were higher than controls (P < 0.001). It may be concluded from the present study that although no statistically significant difference was found between paraoxonase phenotype distributions of controls and CHD patients, a decrease in paraoxonase activity could become a risk factor for this disease. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.